A novel signature based on microvascular invasion predicts the recurrence of HCC

In hepatocellular carcinoma (HCC) patients, microvascular invasion (MVI) is associated with worse outcomes regardless of treatment. No single reliable preoperative factor exists to predict MVI. The aim of the ...
Source: Journal of Translational Medicine - Category: Research Authors: Tags: Research Source Type: research